Chronimed Initiates Preemptive Defense, Bayer Infringement Suit Follows
This article was originally published in The Gray Sheet
Executive Summary
Chronimed's DiaScreen urinalysis test strips for leukocytes do not incorporate analytical processes or agents claimed in Bayer's U.S. patent covering glucose test strip technology, Chronimed maintains in a declaratory judgment action filed against Bayer in Minneapolis federal court.